Cargando…
Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378246/ https://www.ncbi.nlm.nih.gov/pubmed/35981692 http://dx.doi.org/10.1016/j.cmi.2022.07.028 |
| _version_ | 1784768516694474752 |
|---|---|
| author | Zhou, Yuchi Liu, Xiangting Wang, Xia Li, Hui Zeng, Guangting |
| author_facet | Zhou, Yuchi Liu, Xiangting Wang, Xia Li, Hui Zeng, Guangting |
| author_sort | Zhou, Yuchi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9378246 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93782462022-08-16 Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al Zhou, Yuchi Liu, Xiangting Wang, Xia Li, Hui Zeng, Guangting Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-12 2022-08-16 /pmc/articles/PMC9378246/ /pubmed/35981692 http://dx.doi.org/10.1016/j.cmi.2022.07.028 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Zhou, Yuchi Liu, Xiangting Wang, Xia Li, Hui Zeng, Guangting Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title | Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title_full | Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title_fullStr | Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title_full_unstemmed | Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title_short | Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al |
| title_sort | re: ‘association between igg antibody levels and adverse events after first and second bnt162b2 mrna vaccine doses’ by braun et al |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378246/ https://www.ncbi.nlm.nih.gov/pubmed/35981692 http://dx.doi.org/10.1016/j.cmi.2022.07.028 |
| work_keys_str_mv | AT zhouyuchi reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal AT liuxiangting reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal AT wangxia reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal AT lihui reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal AT zengguangting reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal |